Epstein Barr Virus External Quality Assessment

Home - RIQAS - Epstein Barr Virus External Quality Assessment

The RIQAS Epstein Barr Virus EQA programme is designed to monitor the performance of tests used to detect EBV virus antibodies. All samples are conveniently supplied liquid ready-to-use and are suitable for both quantitative and qualitative methods of analysis.

  • Liquid ready-to-use
  • 100% human Plasma
  • Quarterly reporting (3 samples per quarterly distribution)
  • Submit results and view reports online via RIQAS.Net
  • Suitable for both quantitative and qualitative methods of analysis

Not accredited to ISO/IEC 17043

Cat NoKit SizeFrequencyCycle StartAnalytes 
RQ91533 x 1ml
(samples shipped 4 times per year)
Quarterly reporting
(1 x 12 month cycle)
June3

Parameters

  • Anti-EBNA IgG
  • Anti-EBV VCA IgG
  • Anti-EBV VCA IgM

    RIQAS Programmes

Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
  • This field is for validation purposes and should be left unchanged.
×
Kit Insert Request - Reagents
×
Kit Insert Request - Reagents
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
×
Make an Enquiry - Biochip
  • This field is for validation purposes and should be left unchanged.
×
Make an Enquiry - Molecular
  • This field is for validation purposes and should be left unchanged.
×
Randox Feedback Survey